Clinical Trial

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a randomized, placebo-controlled, single ascending dose (SAD) study of SER-252 in participants with Parkinson's Disease (PD) and motor fluctuations.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2026-02-12; most recent amendment 2026-06-03.
Trial Details
NCT Number NCT07422675
Lead Sponsor Serina Therapeutics
Conditions PARKINSON DISEASE (Disorder), Advanced Parkinson's Disease
Enrollment 40 participants
Start Date 2026-02-01
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-05